Rangeley Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rangeley Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-102,000	Closed	-$1.26M	–	108
2024 Q4	$1.26M	Buy	+102,000	New	+$1.17M	1.13%	24

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rangeley Capital's CDMO Position: Q1 2025 in Review

Rangeley Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 102,000 shares — an estimated $1.26M sold.

Rangeley Capital first reported a position in CDMO in Q4 2024 and held it in 1 quarter. The position peaked at $1.26M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Rangeley Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Rangeley Capital sold 102,000 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.26M.
Rangeley Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Rangeley Capital's Avid Bioservices, Inc. Common Stock position peaked at $1.26M in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Rangeley Capital's 13F filing for Q1 2025, filed 14 May 2025.